Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
White spot syndrome virus (WSSV) is a large, double-stranded DNA virus and the sole member of the genus Whispovirus within the family Nimaviridae [1]. It is the causative agent of White Spot Disease (WSD), which is characterized by rapid onset and high mortality rates in a wide range of crustacean species, particularly penaeid shrimp [2]. The viral genome consists of approximately 300 kb and encodes nearly 180 open reading frames, with the gene sequences for envelope proteins like VP28 being critical for host cell attachment and entry [3].\n\nBecause crustaceans lack an adaptive immune system, therapeutic strategies focus on targeting these viral gene sequences using molecular tools like RNA interference (RNAi) to silence viral replication [4]. Experimental treatments often involve the administration of sequence-specific double-stranded RNA (dsRNA) or DNA vaccines that encode viral antigens to prime the host's innate immune defenses [5]. Additionally, small molecules and natural extracts have been explored for their ability to interfere with the expression of these viral sequences or the function of their protein products [6]. Despite significant research, the practical application of these gene-targeted therapies in aquaculture is hindered by delivery difficulties and the potential for environmental impact [7]. Monitoring the efficacy of such treatments typically involves quantifying viral DNA loads and assessing the expression of targeted viral genes [8].
RNA interference-mediated gene silencing of viral mRNA, competitive inhibition of viral envelope proteins to prevent host cell entry, and induction of innate antiviral immunity through pattern recognition receptor activation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on White spot syndrome virus (WSSV) (WSSV).